US Broker Ratings

Neogen Corporation (NEOG) Stock Analysis: Exploring a 63% Potential Upside for Investors

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, presents a compelling opportunity for investors eyeing substantial potential upside. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: Navigating Potential Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, is catching the eye of investors with its potential upside of 10.77%, as indicated by recent analyst ratings...

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 21.71% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, specializes in the development and distribution of both generic and proprietary injectable, inhalation, and intranasal products. With a..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 21.32% Potential Upside for Investors

Pediatrix Medical Group, Inc. (NASDAQ: MD), a prominent player in the healthcare sector, is turning heads with a compelling potential upside of 21.32%, according to the latest analyst ratings. With..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 31% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is capturing significant attention in the biotechnology sector, driven by its robust pipeline and promising market positioning. With a market capitalization of $2.11 billion, Ligand..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating a 28% Potential Upside for Investors

Investors seeking opportunities in the healthcare sector may find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing option. Despite its current challenges, the company presents a notable 28.08% potential upside based..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating the Future of Bioelectric Medicine with an Eye on Growth Potential

Pulse Biosciences, Inc. (NASDAQ: PLSE), a formidable player in the healthcare sector, is making waves in the medical instruments and supplies industry with its pioneering bioelectric medicine technologies. Headquartered in..

89bio, Inc. (ETNB) Stock Analysis: Exploring a Potential 178% Upside in the Biotech Market

89bio, Inc. (NASDAQ: ETNB), a promising player in the biotechnology sector, has caught the attention of investors with its ambitious approach to addressing liver and cardio-metabolic diseases. Specializing in the..

Novavax, Inc. (NVAX) Stock Analysis: Intriguing Potential with Nearly 98% Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, is captivating investor attention with its substantial growth potential. The company, based in Gaithersburg, Maryland, specializes in the development..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 95.69% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a notable player in the biotechnology sector, stands out with a remarkable potential upside of 95.69% based on current analyst ratings. As a biopharmaceutical company..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 72% Potential Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering biotechnology company based in the United Kingdom, is capturing attention with its promising portfolio of immunotherapies targeting cancer, infectious diseases, and autoimmune disorders...

Viking Therapeutics, Inc. (VKTX): Investor Outlook with a Potential 227% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its compelling pipeline of novel therapies aimed at treating metabolic and endocrine disorders...

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 154.87% Potential Upside in the Biotechnology Arena

Innoviva, Inc. (NASDAQ: INVA) stands out as a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.35 billion, this U.S.-based company has..

Belite Bio, Inc (BLTE) Investor Outlook: Exploring the 38% Potential Upside in Biotechnology

Belite Bio, Inc (BLTE) stands out in the competitive biotechnology sector with its innovative approach to tackling unmet medical needs in retinal degenerative diseases. With a market capitalization of $2..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Complex Terrain of Early Cancer Detection with a Market Cap of $1.44 Billion

GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare industry with its innovative approach to cancer diagnostics. Specializing in multi-cancer early detection testing, GRAIL is positioned at the forefront..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 54.50% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a significant player in the healthcare sector, specifically within the health information services industry. With its innovative platform offering consumers the ability to..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 211.57% Potential Upside in Biotech

Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently a standout in the biotechnology sector, captivating investor interest with a remarkable potential upside of 211.57%. Headquartered in Waltham, Massachusetts, Dyne is at..

ANI Pharmaceuticals, Inc. (ANIP): Growth Potential and a 28.47% Upside Ignite Investor Interest

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is capturing the attention of investors with its promising outlook in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

Warby Parker Inc. (WRBY) Stock Analysis: Strong Buy Ratings Amidst a Challenging Valuation Landscape

Warby Parker Inc. (NYSE: WRBY), a key player in the Healthcare sector’s Medical Instruments & Supplies industry, continues to capture investor attention with its innovative approach to eyewear. With a..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Potential 30% Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, particularly within the medical device industry, presents an intriguing opportunity for investors seeking growth in a niche market...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds